AAV vectors Muscle Mass cytometry Adjudication Deep immune profiling Gene therapy Anti-synthetase syndrome Anti-drug antibodies Interferon Anti-MDA5 autoantibodies Antisynthetase IMNM Middle Aged Adeno-associated virus Adverse drug reactions Cytokines Anti-interleukin-6 Auto‐antibodies Case reports Data integration Arthritis Dependovirus/genetics/immunology Autoimmunity Acute Kidney Injury/epidemiology/etiology Autoantibody Antisynthétase Anémie hémolytique Active Dermatomyositis Biomarker DM Anticorps spécifique des myosites Assisted communication devices Cancer AAV vector Inflammation Auto-antibodies Antisynthetase syndrome Aldostérone Anticorps anti-agalsidase Antibodies Anti-IgE IgG Antibody responses Myocarditis Skeletal muscle Cardio-oncology Antiphospholipid syndrome Adult Biomarqueurs Abnormal movement Sphingosine-1-phosphate Interstitial lung disease Amyotrophy Humans COVID-19 Biomarkers Anti‐mitochondrial antibodies Agalsidase Inborn errors of metabolism Anti-agalsidase antibodies Adolescence Inflammatory myopathy Idiopathic inflammatory myopathies Inclusion body myositis Female AAV antibody Acid-alpha-glucosidase Fabry disease Amyotrophic lateral sclerosis Pharmacology B-lymphocyte Myositis and muscle disease AAV humoral immunity AAV Adeno-associated virus vector Analyses multidimensionnelles Biopsy Outcome measures Prognosis Immunotherapy Male Auto-immunité Myositis Adeno-associated vector Systems biology B cell homeostasis Aged Animals Autoantibodies IBM Machine learning Anti-Mi2 Immune checkpoint inhibitors Bioelectrical impedance analysis Multidisciplinarity Autoimmune diseases Aldosterone Myopathy Lysosomal storage diseases Polymyositis